GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LivaNova PLC (NAS:LIVN) » Definitions » Cyclically Adjusted PB Ratio

LIVN (LivaNova) Cyclically Adjusted PB Ratio : 1.30 (As of May. 29, 2025)


View and export this data going back to 1993. Start your Free Trial

What is LivaNova Cyclically Adjusted PB Ratio?


LivaNova Cyclically Adjusted PB Ratio Historical Data

The historical data trend for LivaNova's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LivaNova Cyclically Adjusted PB Ratio Chart

LivaNova Annual Data
Trend Apr15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.02 3.56 1.96 1.68 1.41

LivaNova Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.79 1.72 1.63 1.41 1.18

Competitive Comparison of LivaNova's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, LivaNova's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LivaNova's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where LivaNova's Cyclically Adjusted PB Ratio falls into.


;
;

LivaNova Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

LivaNova's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=43.17/33.23
=1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LivaNova's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, LivaNova's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=18.97/136.1000*136.1000
=18.970

Current CPI (Mar. 2025) = 136.1000.

LivaNova Quarterly Data

Book Value per Share CPI Adj_Book
201504 10.639 99.900 14.494
201507 11.276 100.000 15.347
201510 5.700 100.300 7.734
201603 37.244 100.400 50.487
201606 37.166 101.000 50.082
201609 37.137 101.500 49.797
201612 35.540 102.200 47.329
201703 36.050 102.700 47.774
201706 38.276 103.500 50.332
201709 39.718 104.300 51.828
201712 37.594 105.000 48.729
201803 37.560 105.100 48.639
201806 36.700 105.900 47.166
201809 36.668 106.600 46.815
201812 31.194 107.100 39.641
201903 30.771 107.000 39.140
201906 30.653 107.900 38.664
201909 30.895 108.400 38.790
201912 28.563 108.500 35.829
202003 28.669 108.600 35.929
202006 27.394 108.800 34.268
202009 27.796 109.200 34.643
202012 22.798 109.400 28.362
202103 21.819 109.700 27.070
202106 21.241 111.400 25.951
202109 24.661 112.400 29.861
202112 24.307 114.700 28.842
202203 24.176 116.500 28.243
202206 23.960 120.500 27.062
202209 21.429 122.300 23.847
202212 22.545 125.300 24.488
202303 22.828 126.800 24.502
202306 23.047 129.400 24.240
202309 22.752 130.100 23.801
202312 23.696 130.500 24.713
202403 22.559 131.600 23.330
202406 22.885 133.000 23.418
202409 24.126 133.500 24.596
202412 24.292 135.100 24.472
202503 18.970 136.100 18.970

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


LivaNova  (NAS:LIVN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


LivaNova Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of LivaNova's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LivaNova Business Description

Traded in Other Exchanges
Address
20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Executives
Francesco Bianchi director C/O LIVANOVA PLC, 5 MERCHANT SQUARE, LONDON X0 W2 1AY
Daniel Jeffrey Moore director 100 CYBERONICS BVLD, HOUSTON TX 77058
James Christopher Barry director 7475 LUSK BLVD, SAN DIEGO CA 92121
Damien Mcdonald officer: COO 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY
Michael Damon Hutchinson officer: Chief Legal Officer 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Brooke Story director C/O SIGILON THERAPEUTICS, INC., 100 BINNEY STREET, SUITE 600, CAMBRIDGE MA 02142
Peter M Wilver director
Alfred J Novak director 325 NE 6TH ST, BOCA RATON FL 33432
William A Kozy director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Marco Dolci officer: SVP Global Operations, R&D VIA BENIGNO CRESPI 17, MILAN L6 20159
Todd C Schermerhorn director C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974
Alex Shvartsburg officer: Interim CFO 20 EASTBOURNE TERRACE, LONDON X0 W26LG
Roy Khoury officer: President, International 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY
Thad Allen Huston officer: Chief Financial Officer 941 BLOOMFIELD ST, HOBOKEN NJ 07030
Seng Stacy Enxing director C/O HILL-ROM HOLDINGS, INC., SUITE 4100 180 NORTH STETSON AVENUE, CHICAGO IL 60601